Literature DB >> 15121717

Apparent modulation of CD20 by rituximab: an alternative explanation.

Mark S Cragg, Mike C Bayne, Timothy M Illidge, Thomas Valerius, Peter W N Johnson, Martin J Glennie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15121717     DOI： 10.1182/blood-2003-12-4384

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  2 in total

1.  Treatment Strategies for Patients with Diffuse Large B-Cell Lymphoma: Past, Present, and Future.

Authors:  Rajni Sinha; Loretta Nastoupil; Christopher R Flowers
Journal:  Blood Lymphat Cancer       Date:  2012-04-19

2.  Impact of pretransplant rituximab induction on highly sensitized kidney recipients: comparison with non-rituximab group.

Authors:  Young Hae Song; Kyu Ha Huh; Yu Seun Kim; Hyung Soon Lee; Myoung Soo Kim; Soo Jin Kim; Hyun Jung Kim; Soon Il Kim; Dong Jin Joo
Journal:  J Korean Surg Soc       Date:  2012-05-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.